CN109400611B - Synthesis method of 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound - Google Patents

Synthesis method of 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound Download PDF

Info

Publication number
CN109400611B
CN109400611B CN201811130849.5A CN201811130849A CN109400611B CN 109400611 B CN109400611 B CN 109400611B CN 201811130849 A CN201811130849 A CN 201811130849A CN 109400611 B CN109400611 B CN 109400611B
Authority
CN
China
Prior art keywords
formula
reaction
vinyl
dihydropyrrole
quinoxaline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811130849.5A
Other languages
Chinese (zh)
Other versions
CN109400611A (en
Inventor
饶卫东
周媛媛
凌媛
尹栋梁
钟建凯
陈先枭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Forestry University
Original Assignee
Nanjing Forestry University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Forestry University filed Critical Nanjing Forestry University
Priority to CN201811130849.5A priority Critical patent/CN109400611B/en
Publication of CN109400611A publication Critical patent/CN109400611A/en
Application granted granted Critical
Publication of CN109400611B publication Critical patent/CN109400611B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses a novel method for synthesizing 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline derivatives, which comprises the following steps: adding aniline compounds substituted by para-pyrrole, terminal aryne and gold (I) hexafluoroantimonate into anhydrous toluene, heating to 100 ℃, reacting for 24 hours, and performing post-treatment and separation to obtain the 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline derivative. The invention provides a new method for synthesizing 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline derivatives by an aniline compound substituted by ortho-position pyrrole and an aryl terminal alkyne compound. The method has the advantages of simple and convenient operation, mild conditions, good substrate functional group compatibility, high product yield, easy separation of the catalyst and the product and the like, has potential biological activity, and can be used for screening the medicines by subsequently testing the medicinal activity of the medicines.

Description

Synthesis method of 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound
Technical Field
The invention belongs to the technical field of chemical synthesis, and particularly relates to a synthesis method of a 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound.
Background
Quinoxaline compounds are very important heterocyclic compounds, wherein 4, 5-dihydropyrrole [1,2-a ] quinoxaline compounds and analogues thereof are important structural units for forming a plurality of natural product molecules and drug molecules with biological activity, and have wide application prospects in the field of pharmaceutical chemistry research, for example, a 6FQXP structure shown in a formula (10) has a drug effect of resisting HIV virus, and a CB1 receptor antagonist shown in a formula (11) can be used for treating obesity.
Figure BDA0001813503650000011
4, 5-dihydropyrrole [1,2-a ] quinoxaline compounds have important pharmacological action, thus attracting the extensive attention of chemists and developing various methods for synthesizing the compounds. The current synthesis method of 4, 5-dihydropyrrole [1,2-a ] quinoxaline compounds mainly comprises the Pictet-Spengler reaction catalyzed by protonic acid and Lewis acid, which takes aniline and aldehyde substituted by ortho-position pyrrole as raw materials (Eur.J.Org.chem.2011, 6998-7010.; adv.Syn.Cat.2018,360,1334-1339.) and transition metal catalyzed method which takes aniline and alkyne substituted by ortho-position pyrrole as raw materials (J.Am.chem.Soc.,2005, 12717000-17006). Although the method is a general method for synthesizing the 4, 5-dihydropyrrole [1,2-a ] quinoxaline compound at present, the method has harsh conditions and needs additional additives for reaction, and more importantly, the method can not carry out functional group reaction on pyrrole ring through one-step reaction. According to the invention, aniline and alkyne substituted by ortho-position pyrrole are used as raw materials, and a gold complex is used as a catalyst, so that a product different from other methods is obtained, the reaction with two molecules of alkyne is realized, and the multi-functionalized 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound is efficiently constructed.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides a synthesis method of a 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound with good yield.
In order to solve the technical problems, the invention provides the following technical scheme: the invention relates to a synthesis method of a 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound, which comprises the steps of taking an aniline compound substituted by ortho-position pyrrole shown in a formula (2) and aryl terminal alkyne shown in a formula (3) as raw materials under the action of a gold catalyst, reacting in a solvent under the action of the gold catalyst, carrying out thin-plate chromatography tracking reaction until the reaction is complete to obtain a reaction mixture, and carrying out post-treatment on the reaction mixture to obtain the 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound shown in the formula (1); the chemical reaction formula is shown as follows:
Figure BDA0001813503650000021
in the formula (2) or the formula (1), R is hydrogen, methyl, aryl or halogen; in formula (3) or formula (1), Ar is phenyl, naphthyl, heterocyclic ring (including but not limited to furan ring, thiophene ring, pyridine ring, etc.), substituted heterocyclic ring, or phenyl substituted by methyl, methoxy, halogen.
Further, the solvent is any one of dichloroethane, nitromethane, toluene, tetrahydrofuran, acetonitrile or chlorobenzene.
Further, the solvent is toluene.
Further, the gold catalyst is one of the gold catalysts shown below;
Figure BDA0001813503650000031
furthermore, the quantity ratio of the ortho-pyrrole substituted aniline compound to the aryl terminal alkyne is 1:2-1: 5.
Furthermore, the ratio of the amount of the gold catalyst to the amount of the ortho-pyrrole substituted aniline compound substance is 0.01-0.2.
Furthermore, the reaction temperature is 25-100 ℃, and the reaction time is 1-24 hours.
Further, the reaction post-treatment method comprises the following steps: after the reaction, the reaction mixture was concentrated by rotary evaporation and separated by silica gel column chromatography using petroleum ether: gradient elution is carried out by using mixed solution of ethyl acetate with the volume ratio of 20:1-5:1 as eluent to obtain the 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound shown in the formula (1).
Has the advantages that: the synthesis method has the advantages of good regioselectivity, wide range of reaction substrates, simple post-treatment and better yield (68-88%).
(1) The synthesis method takes a gold complex as a catalyst, takes methylbenzene as a solvent, carries out reaction under the condition of heating at 100 ℃, and then carries out post-treatment and separation to obtain the 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound, wherein the product has potential biological activity, and can be subjected to subsequent test on the pharmaceutical activity to carry out drug screening. Can also be used as an important organic intermediate to be applied to the fields of medicines, pesticides and the like.
(2) The 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline derivative prepared by the invention has potential bioactivity, and can be used for screening medicaments by subsequently testing the medicinal activity of the derivative. Can also be used as an important organic intermediate to be applied to the fields of medicines, pesticides and the like.
(3) The invention provides a new method for efficiently synthesizing a 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound by an aniline compound substituted by critical pyrrole and terminal aryne under the action of a gold catalyst. The whole reaction has the advantages of simple and convenient operation, mild condition, good substrate functional group compatibility, high product yield, easy separation of the catalyst and the product and the like.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings needed to be used in the description of the embodiments are briefly introduced below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the drawings without inventive labor; wherein:
FIG. 1 is a single crystal diffractogram of the compound 4- (4-bromophenyl) -1- (1- (4-bromophenyl) vinyl) -4-methyl) -4, 5-dihydropyrrolo [1,2-a ] quinoxaline (1 ae).
Detailed Description
In order to make the aforementioned objects, features and advantages of the present invention comprehensible, embodiments accompanied with examples are described in detail below.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention, but the present invention may be practiced in other ways than those specifically described and will be readily apparent to those of ordinary skill in the art without departing from the spirit of the present invention, and therefore the present invention is not limited to the specific embodiments disclosed below.
Furthermore, reference herein to "one embodiment" or "an embodiment" means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one implementation of the invention. The appearances of the phrase "in one embodiment" in various places in the specification are not necessarily all referring to the same embodiment, nor are separate or alternative embodiments mutually exclusive of other embodiments.
Example 1
The reaction formula is as follows:
Figure BDA0001813503650000041
to a 25mL round-bottomed flask, 2- (1H-1-pyrrolyl) aniline 2a (0.2mmol), phenylacetylene 3a (0.5mmol), toluene 2mL, gold catalyst (4) (acetonitrile) [ (2-biphenyl) di-t-butylphosphine ] gold (I) hexafluoroantimonate (0.01mmol) were added in this order, and the mixture was stirred at 100 ℃ for 24 hours. TLC monitoring reaction, after the reaction, rotary evaporation to remove solvent, the crude product through 280 mesh silica gel column chromatography, using petroleum ether and ethyl acetate (volume ratio is 10:1) mixed solvent as eluent to carry out gradient elution, collecting eluent and rotary evaporation to remove solvent, and the target product 1aa is obtained as white solid (yield is 78%).
1H NMR(400MHz,CDCl3):δ7.32-7.13(m,10H),6.71(t,J=7.24Hz,1H),6.62(d,J=6.92Hz,1H),6.39(t,J=7.26Hz,1H),6.32(s,1H),6.08(s,1H),5.69(s,1H),5.51(s,1H),4.29(s,1H),1.88(s,1H).
13C NMR(100MHz,CDCl3):δ145.9,142.6,139.9,136.2,136.1,130.2,128.3,128.2,127.8,126.9,126.7,126.0,125.9,124.3,118.9,118.7,115.8,113.6,103.7,57.8,29.2.
Example 2
The reaction formula is as follows:
Figure BDA0001813503650000051
to a 25mL round-bottomed flask, 2- (1H-1-pyrrolyl) aniline 2a (0.2mmol), 4-methylphenylacetylene 3b (0.5mmol), toluene 2mL, gold catalyst (4) (acetonitrile) [ (2-biphenyl) di-t-butylphosphine ] gold (I) hexafluoroantimonate (0.01mmol) were added in this order, and the mixture was stirred at 100 ℃ for 24 hours. TLC monitoring reaction, after the reaction, rotary evaporation to remove solvent, the crude product through 300 mesh silica gel column chromatography, using petroleum ether and ethyl acetate (volume ratio of 20: 1) mixed solvent as eluent to carry out gradient elution, collecting eluent and rotary evaporation to remove solvent, and obtaining the target product 1ab as white solid (yield 85%).
1H NMR(400MHz,CDCl3):δ7.26-7.13(m,5H),7.01(q,J=8.00Hz,4H),6.71(t,J=7.56Hz,1H),6.60(d,J=7.72Hz,1H),6.40(t,J=7.70Hz),6.28(d,J=3.44Hz,1H),6.05(d,J=3.4Hz,1H),5.65(s,1H),5.42(s,1H),4.24(br,s,1H),2.24(s,6H),1.85(s,3H).
13C NMR(100MHz,CDCl3):δ143.1,142.5,137.6,137.3,136.2,136.1,130.3,129.0,128.9,126.5,126.1,125.9,124.2,118.9,118.7,115.9,115.1,113.4,103.6,57.5,29.2,21.2,21.0.
Example 3
The reaction formula is as follows:
Figure BDA0001813503650000061
to a 25mL round-bottomed flask, 2- (1H-1-pyrrolyl) aniline 2a (0.2mmol), 4-pentylphenylacetylene 3c (0.5mmol), toluene 2mL, gold catalyst (4) (acetonitrile) [ (2-biphenyl) di-t-butylphosphine ] gold (I) hexafluoroantimonate (0.01mmol) were added in this order, and the mixture was stirred at 100 ℃ for 24 hours. TLC is used for monitoring the reaction, after the reaction is finished, the solvent is removed through rotary evaporation, the crude product is subjected to 200-mesh silica gel column chromatography, gradient elution is carried out by taking a mixed solvent of petroleum ether and ethyl acetate (the volume ratio is 15:1) as an eluent, the eluent is collected, and the solvent is removed through rotary evaporation, so that the target product 1ac is obtained as a white solid (the yield is 88%).
1H NMR(400MHz,CDCl3):δ7.25-7.15(m,5H),7.05-6.98(m,4H),6.71(t,J=7.51Hz,1H),6.61(d,J=7.64Hz,1H),6.40(t,J=7.66Hz,1H),6.28(d,J=3.44Hz,1H),6.02(d,J=3.40Hz,1H),5.66(s,1H),5.43(s,1H),4.24(s,1H),2.52-2.48(m,4H),1.85(s,3H),1.58-1.50(m,5H),1.33-1.19(m,9H),0.90-0.83(m,7H).
13C NMR(100MHz,CDCl3):δ143.2,142.6,142.5,141.5,137.3,136.3,136.1,130.3,128.4,128.2,126.6,126.0,125.9,124.2,118.8,115.8,115.0,113.4,103.6,57.5,35.6,35.5,31.6,31.4,31.03,30.98,29.2,22.6,14.1.
Example 4
The reaction formula is as follows:
Figure BDA0001813503650000062
to a 25mL round-bottomed flask, 2- (1H-1-pyrrolyl) aniline 2a (0.2mmol), 4-chlorophenylacetylene 3c (0.5mmol), toluene 2mL, gold catalyst (4) (acetonitrile) [ (2-biphenyl) di-t-butylphosphine ] gold (I) hexafluoroantimonate (0.01mmol) were added in this order, and the mixture was stirred at 100 ℃ for 24 hours. And (3) monitoring the reaction by TLC, after the reaction is finished, rotationally evaporating to remove the solvent, performing column chromatography on the crude product through 200-300-mesh silica gel, performing gradient elution by using a mixed solvent of petroleum ether and ethyl acetate (the volume ratio is 20: 1-10:1) as an eluent, collecting the eluent, and rotationally evaporating to remove the solvent to obtain the target product 1ad which is a light yellow solid (the yield is 68%).
1H NMR(400MHz,CDCl3):δ7.24-7.13(m,9H),6.74(t,J=7.54Hz,1H),6.63(d,J=7.64Hz,1H),6.42(t,J=7.60Hz,1H),6.32(d,J=3.48Hz,1H),6.07(d,J=3.40Hz,1H),5.66(s,1H),5.53(s,1H),4.25(s,1H),1.85(s,3H).
13C NMR(100MHz,CDCl3):δ144.4,141.5,138.4,135.9,135.8,133.6,132.8,129.7,128.5,128.3,127.9,127.4,125.8,124.6,119.2,118.6,116.4,116.0,113.8,103.8,57.5,29.0.
Example 5
The reaction formula is as follows:
Figure BDA0001813503650000071
to a 25mL round-bottomed flask, 2- (1H-1-pyrrolyl) aniline 2a (0.2mmol), 4-bromophenylacetylene 3c (0.5mmol), toluene 2mL, gold catalyst (4) (acetonitrile) [ (2-biphenyl) di-t-butylphosphine ] gold (I) hexafluoroantimonate (0.01mmol) were added in this order, and the mixture was stirred at 100 ℃ for 24 hours. And (3) monitoring the reaction by TLC, after the reaction is finished, rotationally evaporating to remove the solvent, performing column chromatography on the crude product through 200-300-mesh silica gel, performing gradient elution by using a mixed solvent of petroleum ether and ethyl acetate (the volume ratio is 20: 1-10:1) as an eluent, collecting the eluent, and rotationally evaporating to remove the solvent to obtain a target product 1ae which is a light yellow solid (the yield is 71%).
1H NMR(400MHz,CDCl3):δ7.35-7.25(m,5H),7.17-7.15(m,3H),7.07(d,J=8.16Hz,2H),6.75(t,J=7.50Hz,1H),6.64(d,J=7.72Hz,1H),6.43(t,J=7.64Hz,1H),6.32(d,J=3.12Hz,1H),6.08(s,1H),5.68(s,1H),5.54(s,1H),4.26(s,1H),1.85(s,3H).
13C NMR(100MHz,CDCl3):δ144.9,141.6,138.8,135.8,135.7,131.4,131.3,129.7,128.2,127.8,125.8,124.7,121.9,121.0,119.3,118.5,116.5,116.1,113.9,103.8,57.5,29.0.
Example 6
The reaction formula is as follows:
Figure BDA0001813503650000081
under the protection of argon, a 25mL round-bottom flask was taken, and 2a (0.2mmol), 6-methoxy-2-naphthylyne 3f (0.5mmol), 2mL of toluene, (acetonitrile) [ (2-biphenyl) di-tert-butylphosphine ] gold (I) hexafluoroantimonate (0.01mmol) were added in this order, and the mixture was stirred at 400rpm for 24 hours at 100 ℃. TLC monitoring reaction, after the reaction, using Heidolph rotary evaporator rotary evaporation, its speed of rotation is 200rpm, the temperature is 40 degrees C, the vacuum degree is 0.06Mpa, the processing time is 10 min. And performing 200-300 mesh silica gel column chromatography, wherein an eluent is ethyl acetate: petroleum ether 7:100, isolated to yield the desired product 1af (80% yield).
1H NMR(400MHz,CDCl3):δ7.65-7.53(m,7H),7.46(d,J=8.60Hz,1H),7.31(d,J=8.16Hz,1H),7.23(s,1H),7.10-7.02(m,4H),6.67-6.60(m,2H),6.37-6.32(m,2H),6.10(d,J=3.16Hz,1H),5.80(s,1H),5.54(s,1H),4.33(s,1H),3.86(s,3H),3.84(s,3H),1.96(s,3H).
13C NMR(100MHz,CDCl3):δ157.8,157.7,142.5,141.1,136.3,136.1,135.3,134.2,133.5,130.4,129.9,129.7,128.8,128.4,126.9,126.8,126.0,125.9,125.2,125.1,124.5,124.4,118.9,118.8,118.7,118.6,115.9,115.8,113.6,105.6,105.5,104.0,57.8,55.34,55.28,28.9.
Example 7
The reaction formula is as follows:
Figure BDA0001813503650000082
a25 mL round-bottom flask was charged with 2a (0.2mmol),3g (0.5mmol) and 2mL of toluene, (acetonitrile) [ (2-biphenyl) di-t-butylphosphine ] gold (I) hexafluoroantimonate (0.01mmol) in this order under an argon atmosphere, and the mixture was stirred at 400rpm for 24 hours at 100 ℃. TLC monitoring reaction, after the reaction, using Heidolph rotary evaporator rotary evaporation, its speed of rotation is 200rpm, the temperature is 40 degrees C, the vacuum degree is 0.06Mpa, the processing time is 10 min. And performing 200-300 mesh silica gel column chromatography, wherein an eluent is ethyl acetate: petroleum ether 6:100, the desired product 1ag was isolated (yield 76%).
1H NMR(400MHz,CDCl3):δ7.28(t,J=7.80Hz,2H),7.21-7.05(m,3H),6.97(s,1H),6.89(s,1H),6.80(t,J=6.50Hz,1H),6.67(d,J=7.72Hz,1H),6.50(t,J=7.74Hz,1H),6.29(d,J=3.44Hz,1H),6.00(d,J=3.4Hz,1H),5.68(s,1H),5.42(s,1H),4.15(s,1H),1.90(s,3H).
13C NMR(100MHz,CDCl3):δ147.9,141.9,137.3,136.2,135.9,130.3,126.3,125.9,125.80,125.77,125,6,124.4,123.0,120.8,119.1,118.5,115.7,114.7,112.9,102.9,55.7,28.7.
Example 8
The reaction formula is as follows:
Figure BDA0001813503650000091
under the protection of argon, a 25mL round-bottom flask was taken, 4-methyl-2- (1H-1-pyrrolyl) aniline 2b (0.2mmol), phenylacetylene 3a (0.5mmol), toluene 2mL, (acetonitrile) [ (2-biphenyl) di-tert-butylphosphine ] gold (I) hexafluoroantimonate (0.01mmol) were added in this order, and the mixture was stirred at 400rpm for 24 hours at 100 ℃. TLC monitoring reaction, after the reaction, using Heidolph rotary evaporator rotary evaporation, its speed of rotation is 200rpm, the temperature is 40 degrees C, the vacuum degree is 0.06Mpa, the processing time is 10 min. And performing 200-300 mesh silica gel column chromatography, wherein an eluent is ethyl acetate: petroleum ether 5:100, isolated to yield the target product 1ba (77% yield).
1H NMR(300MHz,CDCl3):δ7.37-7.10(m,10H),δ6.97(s,1H),δ6.47(t,J=8.73Hz,2H),δ6.33(d,J=3.45Hz,1H),δ6.06(d,J=3.39Hz,1H),δ5.61(d,J=1.53Hz,1H),δ5.52(d,J=1.44Hz,1H),δ1.90(s,3H),δ1.83(s,3H).
13C NMR(75MHz,CDCl3):δ146.0,143.0,140.2,136.2,133.5,130.2,128.2,127.7,126.8,126.7,125.9,125.8,124.6,119.6,115.7,115.6,113.6,103.6,57.7,29.2,20.6.
Example 9
The reaction formula is as follows:
Figure BDA0001813503650000101
under the protection of argon, a 25mL round-bottom flask was taken, 4-chloro-2- (1H-1-pyrrolyl) aniline 2c (0.2mmol), phenylacetylene 3a (0.5mmol), toluene 2mL, (acetonitrile) [ (2-biphenyl) di-tert-butylphosphine ] gold (I) hexafluoroantimonate (0.01mmol) were added in this order, and the mixture was stirred at 400rpm for 24 hours at 100 ℃. TLC monitoring reaction, after the reaction, using Heidolph rotary evaporator rotary evaporation, its speed of rotation is 200rpm, the temperature is 40 degrees C, the vacuum degree is 0.06Mpa, the processing time is 10 min. And performing 200-300 mesh silica gel column chromatography, wherein an eluent is ethyl acetate: petroleum ether 7:100, isolated to yield the desired product 1ca (76% yield).
1H NMR(500MHz,CDCl3):δ7.23-7.15(m,12H),6.62(d,J=6.65Hz,1H),6.49(d,J=8.35Hz,1H),6.38(d,J=3.25Hz,1H),6.10(s,1H),5.67(s,1H),5.55(s,1H),4.40(br,s,1H),1.86(s,3H).
13C NMR(125MHz,CDCl3):δ145.5,142.5,139.8,135.9,134.6,130.4,128.4,128.3,128.0,127.1,126.8,126.5,125.8,123.9,123.5,119.0,116.5,116.4,114.0,104.1,57.8,29.1.
Example 10
The reaction formula is as follows:
Figure BDA0001813503650000102
under the protection of argon, a 25mL round-bottom flask was taken, 4-chloro-2- (1H-1-pyrrolyl) aniline 2c (0.2mmol),3b (0.5mmol), toluene 2mL, (acetonitrile) [ (2-biphenyl) di-tert-butylphosphine ] gold (I) hexafluoroantimonate (0.01mmol) were added in this order, and the mixture was stirred at 400rpm for 24 hours at 100 ℃. TLC monitoring reaction, after the reaction, using Heidolph rotary evaporator rotary evaporation, its speed of rotation is 200rpm, the temperature is 40 degrees C, the vacuum degree is 0.06Mpa, the processing time is 10 min. And performing 200-300 mesh silica gel column chromatography, wherein an eluent is ethyl acetate: petroleum ether 7:100, the desired product 1cb was isolated (yield 68%).
1H NMR(500MHz,CDCl3):δ7.29(d,J=1.85Hz,1H),7.16(t,J=8.50Hz,4H),7.08-7.04(m,4H),6.68(dd,J=1.90,8.25Hz,1H),6.53(d,J=8.30Hz,1H),6.89(d,J=3.35Hz,1H),6.12(s,1H),5.68(d,J=1.40Hz,1H),5.52(s,1H),2.29(s,3H),2.28(s,3H),1.89(s,3H).
13C NMR(125MHz,CDCl3):δ142.6,142.4,137.8,137.0,136.7,136.0,134.7,130.6,129.1,129.0,126.6,125.7,123.9,123.5,118.9,116.5,115.7,113.9,104.0,57.6,29.2,21.2,21.0.
Example 11
The invention relates to a synthesis method of a 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound, which comprises the steps of taking an aniline compound substituted by ortho-position pyrrole shown in a formula (2) and aryl terminal alkyne shown in a formula (3) as raw materials under the action of a gold catalyst, reacting in a solvent under the action of the gold catalyst, carrying out thin-plate chromatography tracking reaction until the reaction is complete to obtain a reaction mixture, and carrying out post-treatment on the reaction mixture to obtain the 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound shown in the formula (1); the chemical reaction formula is shown as follows:
Figure BDA0001813503650000111
in the formula (2) or the formula (1), R is hydrogen, methyl, aryl or halogen; in formula (3) or formula (1), Ar is phenyl, naphthyl, heterocyclic ring (including but not limited to furan ring, thiophene ring, pyridine ring, etc.), substituted heterocyclic ring, or phenyl substituted by methyl, methoxy, halogen.
The solvent is dichloroethane.
The gold catalyst is one of the following gold catalysts;
Figure BDA0001813503650000121
the quantity ratio of the aniline compound substituted by the ortho-position pyrrole to the aryl terminal alkyne is 1: 2.
The ratio of the amount of the gold catalyst to the amount of the ortho-pyrrole substituted aniline compound substance is 0.01.
The reaction temperature is 25 ℃, and the reaction time is 20 hours.
Example 12
The invention relates to a synthesis method of a 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound, which comprises the steps of taking an aniline compound substituted by ortho-position pyrrole shown in a formula (2) and aryl terminal alkyne shown in a formula (3) as raw materials under the action of a gold catalyst, reacting in a solvent under the action of the gold catalyst, carrying out thin-plate chromatography tracking reaction until the reaction is complete to obtain a reaction mixture, and carrying out post-treatment on the reaction mixture to obtain the 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound shown in the formula (1); the chemical reaction formula is shown as follows:
Figure BDA0001813503650000122
in the formula (2) or the formula (1), R is hydrogen, methyl, aryl or halogen; in formula (3) or formula (1), Ar is phenyl, naphthyl, heterocyclic ring (including but not limited to furan ring, thiophene ring, pyridine ring, etc.), substituted heterocyclic ring, or phenyl substituted by methyl, methoxy, halogen.
The solvent is nitromethane.
The gold catalyst is one of the following gold catalysts;
Figure BDA0001813503650000131
the quantity ratio of the aniline compound substituted by the ortho-position pyrrole to the aryl terminal alkyne is 1: 5.
The ratio of the amount of the gold catalyst to the amount of the ortho-pyrrole substituted aniline compound substance is 0.2.
The reaction temperature is 80 ℃, and the reaction time is 1 hour.
Example 13
The invention relates to a synthesis method of a 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound, which comprises the steps of taking an aniline compound substituted by ortho-position pyrrole shown in a formula (2) and aryl terminal alkyne shown in a formula (3) as raw materials under the action of a gold catalyst, reacting in a solvent under the action of the gold catalyst, carrying out thin-plate chromatography tracking reaction until the reaction is complete to obtain a reaction mixture, and carrying out post-treatment on the reaction mixture to obtain the 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound shown in the formula (1); the chemical reaction formula is shown as follows:
Figure BDA0001813503650000132
in the formula (2) or the formula (1), R is hydrogen, methyl, aryl or halogen; in formula (3) or formula (1), Ar is phenyl, naphthyl, heterocyclic ring (including but not limited to furan ring, thiophene ring, pyridine ring, etc.), substituted heterocyclic ring, or phenyl substituted by methyl, methoxy, halogen.
The solvent is any one of tetrahydrofuran, acetonitrile or chlorobenzene.
The gold catalyst is one of the following gold catalysts;
Figure BDA0001813503650000141
the quantity ratio of the aniline compound substituted by the ortho-position pyrrole to the aryl terminal alkyne is 1: 3.
The ratio of the amount of the gold catalyst to the amount of the ortho-pyrrole substituted aniline compound substance is 0.1.
The reaction temperature is 25-100 ℃, and the reaction time is 24 hours.
It should be noted that the above-mentioned embodiments are only for illustrating the technical solutions of the present invention and not for limiting, and although the present invention has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions may be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention, which should be covered by the claims of the present invention.

Claims (4)

1. A synthetic method of 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compounds is characterized by comprising the following steps: under the action of a gold catalyst, taking an aniline compound substituted by critical pyrrole shown in a formula (2) and an alkyne compound shown in a formula (3) as raw materials, reacting in a solvent under the action of the gold catalyst, carrying out thin-plate chromatography tracking reaction until the reaction is complete to obtain a reaction mixture, and carrying out post-treatment on the reaction mixture to obtain a 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound shown in the formula (1); the chemical reaction formula is shown as follows:
Figure 416363DEST_PATH_IMAGE002
in the formula (2) or the formula (1), R is hydrogen, methyl, aryl or halogen; in the formula (3) or the formula (1), Ar is phenyl, naphthyl, heterocyclic group, substituted heterocyclic group, or phenyl substituted by methyl, methoxy or halogen;
the solvent is toluene; the gold catalyst is a gold catalyst shown as the following formula:
Figure 192558DEST_PATH_IMAGE004
the mass ratio of the aniline compound substituted by the ortho-position pyrrole to the alkyne compound is 1:2-1: 5.
2. The method for synthesizing 1-vinyl-4, 5-dihydropyrrolo [1,2-a ] quinoxaline compound according to claim 1, wherein: the ratio of the amount of the gold catalyst to the amount of the ortho-pyrrole substituted aniline compound substance is 0.01-0.2.
3. The method for synthesizing 1-vinyl-4, 5-dihydropyrrolo [1,2-a ] quinoxaline compound according to claim 1, wherein: the reaction temperature is 25-100 ℃, and the reaction time is 1-24 hours.
4. The method for synthesizing 1-vinyl-4, 5-dihydropyrrolo [1,2-a ] quinoxaline compound according to claim 1, wherein: the reaction post-treatment method comprises the following steps: after the reaction, the reaction mixture was concentrated by rotary evaporation and separated by silica gel column chromatography using petroleum ether: gradient elution is carried out by using mixed solution of ethyl acetate with the volume ratio of 20:1-5:1 as eluent to obtain the 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound shown in the formula (1).
CN201811130849.5A 2018-09-27 2018-09-27 Synthesis method of 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound Active CN109400611B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811130849.5A CN109400611B (en) 2018-09-27 2018-09-27 Synthesis method of 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811130849.5A CN109400611B (en) 2018-09-27 2018-09-27 Synthesis method of 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound

Publications (2)

Publication Number Publication Date
CN109400611A CN109400611A (en) 2019-03-01
CN109400611B true CN109400611B (en) 2021-08-24

Family

ID=65466450

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811130849.5A Active CN109400611B (en) 2018-09-27 2018-09-27 Synthesis method of 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound

Country Status (1)

Country Link
CN (1) CN109400611B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110592157B (en) * 2019-10-09 2021-01-01 吉林大学 Method for synthesizing quinoxaline compound by double-protein catalytic cascade reaction
CN114957085B (en) * 2022-05-19 2023-11-14 华南师范大学 Synthetic method and application of polycyano substituted indole heterocyclic compound

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3939159A (en) * 1974-05-29 1976-02-17 American Hoechst Corporation Spiro(pyrrolo (1,2-A)quinoxalines)
CN101003462A (en) * 2007-01-25 2007-07-25 中国林业科学研究院林产化学工业研究所 Method for preparing 1,3 propylene glycol by using glycerol method
CN103333171A (en) * 2013-06-17 2013-10-02 南京工业大学 Synthetic method of pyrrole [1,2-a ] quinoxaline derivative
CN108409743A (en) * 2018-03-07 2018-08-17 兰州大学 A kind of preparation method of pyrrolo- [1,2-a] quinoxaline compounds of alkyl nitrile substitution

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3939159A (en) * 1974-05-29 1976-02-17 American Hoechst Corporation Spiro(pyrrolo (1,2-A)quinoxalines)
CN101003462A (en) * 2007-01-25 2007-07-25 中国林业科学研究院林产化学工业研究所 Method for preparing 1,3 propylene glycol by using glycerol method
CN103333171A (en) * 2013-06-17 2013-10-02 南京工业大学 Synthetic method of pyrrole [1,2-a ] quinoxaline derivative
CN108409743A (en) * 2018-03-07 2018-08-17 兰州大学 A kind of preparation method of pyrrolo- [1,2-a] quinoxaline compounds of alkyl nitrile substitution

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Cyclization of Indoles and Enol Ethers with Alkynes Catalyzed by Platinum and Gold";Catalina Ferrer Llabrés,;《Catalan Insitute of Chemical Research》;20081231;摘要、正文第61和74-75页 *
"Synthesis of Multiple-Substituted Pyrroles via Gold(I)-Catalyzed Hydroamination/Cyclization Cascade" 及其Supporting Information;Xiangdong Li等,;《Org. Lett.》;20150601;第17卷;第2984-2987页及其Supporting Information第S1-S143页 *
"Synthesis of Pyrrolo[1,2-a]quinoxalines via Gold(I)-Mediated Cascade Reactions";Guannan Liu等,;《ACS Comb. Sci.》;20110413;第13卷;第209-213页 *

Also Published As

Publication number Publication date
CN109400611A (en) 2019-03-01

Similar Documents

Publication Publication Date Title
CN110746335B (en) Polysubstituted pyrrole compound and synthesis method thereof
CN105001028A (en) Synthesis method for asymmetric conjugate diyne compound
CN110105305B (en) Transition metal catalyzed C-H activation/cyclization synthesis 1,2-benzothiazine derivative green synthesis method
CN109400611B (en) Synthesis method of 1-vinyl-4, 5-dihydropyrrole [1,2-a ] quinoxaline compound
Liu et al. Asymmetric synthesis of β-aryl-β-trifluoromethyl-β-aminoarones via Mannich-type reactions of ketone enolates with chiral aryl CF3-substituted N-tert-butanesulfinyl ketimines
CN108148069B (en) Synthetic method of furanone pyridone compound
CN109053618A (en) Preparation method of oxazole derivative
CN111362895A (en) Synthesis method of naphthofuran derivative, naphthofuran derivative and application
CN104557957B (en) Synthetic method of spiro-oxoindole ethylene oxide derivative
Debnath et al. Metal-Free Indole–Phenacyl Bromide Cyclization: A Regioselective Synthesis of 3, 5-Diarylcarbazoles
CN114989178B (en) Spiro [ beta-lactam-3, 3' -oxindole ] derivative and preparation method and application thereof
CN115477627B (en) Polysubstituted 2-furanone compound and synthesis method thereof
CN108689892A (en) 3- sulfonylations-indane ketone compounds and preparation method thereof
CN113387886A (en) 2-aminodibenzo [ c, e ] azepine compound and synthetic method thereof
CN116768895A (en) Synthesis method of chiral polycyclic indole compound
Zhang Synthesis of Diarylmethanes via Pd-Catalyzed Coupling of Aryltosylates with Benzyltitanium Reagents
CN102659512B (en) Preparation method of halogenated benzo [ a ] fluorenol
CN106883188B (en) 5-hydrogen-1, 4-benzodiazepine compound and synthesis method thereof
CN109956893B (en) Preparation method of polysubstituted 3-aminopyrrole compound
CN105693778A (en) N-methoxyl formamide-orientated method for synthesizing ferrocene and pyridone derivative
CN101041636B (en) Method for synthesizing heterocyclic ketenes amine condensation derivatives
CN104151314A (en) Naphthoimidazopyridine compound and preparation method thereof
CN113200980B (en) Method for synthesizing indolizine compound under catalysis of silver
CN116462619B (en) Preparation method of cyclopentenone derivative
Li et al. A facile copper salts-mediated conversion of thioamides to N-thioacylamidines, amidines, and amides

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant